As of May 22
| -0.05 / -0.11%|
The 8 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 61.00, with a high estimate of 79.00 and a low estimate of 45.00. The median estimate represents a +32.03% increase from the last price of 46.20.
The current consensus among 8 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.